the aid library

LIST OPTIONS

Filter

1682

Sort by:

Direction:

Download (505)

View PDF (2120)

Technical meeting to support Ebola affected countries on the recovery and resilience plans with a focus on GAVI, the Global Fund and other partners' funding - Report, 9-11 June 2015

World Health Organization (2015)

The objectives of the meeting were to agree on coordinated and aligned support to the 3 countries’ national health recovery plans (Guinea, Liberia, Sierra Leone); to identify cross-cutting areas and opportunities for integration; to identify ways to improve implementation modalities; and to identi... more

Download (567)

View PDF (1718)

Medical eligibility criteria for contraceptive use (5 edition)

World Health Organization WHO (2015)

This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, prsents current World Health Organization (WHO) guidance on the safety of various contraceptive e- m... more

Download (224)

View PDF (390)

Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis

World Health Organization (2017) C_WHO

Download (378)

View PDF (787)

Uganda: Annual Pharmacovigilance Report July 2015 – June 2016

National Drug Authority, Uganda (2016) C1

Download (106)

View PDF (147)

Responsible use of antibiotics in aquaculture

Hernández Serrano, P. Food and Agriculture Organization (FAO) (2005) C2

In aquaculture, antibiotics have been used mainly for therapeutic purposes and as prophylactic agents. The contribution to antimicrobial resistance of antibiotics used in aquaculture is reviewed here, using a risk analysis framework. Some recommendations on responsible conduct in this context are pr... more

Download (90)

View PDF (589)

Curbing Antimicrobial Resistance in Food Animal Production

Johns Hopkins Center for a Livable Future (2016) C2

Antimicrobials are widely used in food animal production, and use is rapidly increasing. In an era of growing demand for animal products, there is an increasing trend towards the industrial production of food animals, especially in lower- and middle-income countries (LMICs). One hallmark of this me... more

Download (80)

View PDF (789)

Antimicrobial resistance in the WHO African region: current status and roadmap for action

Essack S.Y., A.T. Desta, R.E. Abotsi et al. Journal of Public Health (2016) C2

The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul... more

Download (135)

View PDF (168)

Technical brief on water, sanitation, hygiene (WASH) and wastewater management to prevent infections and reduce the spread of antimicrobial resistance (AMR)

World Health Organization WHO, Food and Agriculture Organization FAO, World Organization for Animal Health OIE (2020) C_WHO

Improvements in water sanitation and hygiene (WASH) and wastewater management in all sectors are critical elements of preventing infections and reducing the spread of antimicrobial resistance (AMR) as identified in the Global Action Plan to combat AMR. Yet, at present, WASH and wastewater management... more

Download (220)

View PDF (280)

Клінічна Допомога при Важкій Гострій Респіраторній Iнфекції
recommended

World Health Organization WHO (2020) C_WHO

Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation

Download (219)

View PDF (162)

The State of the World’s Antibiotics Report 2021

Siriam, A.; et al. The Center For Disease Dynamics, Economics & Policy CDDEP (2021) CC

A Global Analysis of Antimicrobial Resistance and Its Drivers. Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic... more

Download (168)

View PDF (165)

Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine

World Health Organization WHO (2022) C_WHO

6 June 2022 These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. Th... more

Download (136)

View PDF (176)

The immunological basis for immunization series: module 15: meningococcal disease, update 2020

World Health Organization WHO (2020) C_WHO

Download (104)

View PDF (174)

Guidance for clinical case management of thrombosis with thrombocytopenia syndrome‎ following vaccination to prevent coronavirus disease (‎COVID-19)‎ (Arabic)

World Health Organization WHO (2021) C_WHO

interim guidance, 19 July 2021 (arabic version)

Download (109)

View PDF (153)

Neurology and COVID-19: Scientific brief, 29 September 2021

World Health Organization WHO (2021) C_WHO

29 September 2021

Download (107)

View PDF (123)

Health systems resilience during COVID-19: lessons for building back better

Sagan, A.; E. Webb, M. Mckee et al. World Health Organization WHO (2021) C_WHO

Download (129)

View PDF (211)

Coronavirus SARS-CoV-2/ COVID-19 Pandemic: Information and interim guidelines for pharmacists and the pharmacy workforce

International Pharmaceutical Federation (FIP) (2020) CC

The purpose of this document is to provide relevant information and guidelines on coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a primary care context (i.e. community phar... more

Download (103)

View PDF (431)

The TAP toolbox: exercises, tools and templates to support your tailoring antimicrobial resistance programmes plan

World Health Organization WHO (2021) C_WHO

This Tailoring Antimicrobial Resistance Programmes (‎TAP)‎ process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (‎AMR)‎ in their countries. AMR is a complex problem requiring unique, context-specific solutions. This TAP Toolbo... more

Download (41)

View PDF (74)

African Union AMR Landmark Report: Voicing African Priorities on the Active Pandemic

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2...020 – 2025, which is tailored to meet the specific needs of African nations through a coordinated approach. While most countries in the region have developed and prioritized National Action Plans (NAPs) to tackle AMR, the overall response remains inadequate given the magnitude of the threat, which endangers human, animal, environmental, aquatic, and plant health. Africa bears a significant burden of infectious diseases, accounting for approximately 95% of malaria deaths, 70% of people living with HIV, and 25% of TB deaths globally. In 2019, AMR was linked to approximately 55,000 deaths from HIV, 30,000 from malaria, and 255,000 overall. Major drivers of AMR in the region include the overuse and misuse of antimicrobials in human and food systems, migration, suboptimal vaccination rates, and environmental contamination from hospital and pharmaceutical effluents. Additionally, there is a lack of access to quality-assured antimicrobials and diagnostics, compounded by inadequate knowledge about AMR. Unlike high-income countries, where indiscriminate antimicrobial use is the primary factor driving AMR, African countries face additional challenges, including a lack of access to clean and safe water, poor Water, Sanitation, and Hygiene (WASH) programs, inadequate infection prevention measures, and suboptimal vaccinations for preventable diseases. One in three hospitals in the region lacks clean, safe running water, and one in eight people defecate openly due to inadequate sanitation. Investments in WASH, infection prevention, and biosecurity could save approximately 700,000 lives annually. Addressing AMR in Africa requires a comprehensive, multi-sectoral approach involving the entire society. Sustainable access to antimicrobials, including antibiotics, vaccines, and therapeutics, is crucial, as lack of access leads to more morbidity and mortality than AMR itself. Support for the region should focus on preventing infections, strengthening health and food systems, developing human resources, ensuring sustainable access to diagnostics and therapeutics, and investing in laboratory infrastructure to support surveillance and data generation. more

Download (16)

View PDF (55)

WHO consolidated guidelines on tuberculosis Module 1: prevention - tuberculosis preventive treatment, second edition

World Health Organisation (WHO) (2024) C_WHO

About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im... more

Download (12)

View PDF (9)

Antimicrobial Resistance Curriculum Assessment Tool for Medical Education

World Health Organisation (WHO) (2024) C_WHO

The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ... more

Клінічна Допомога при Важкій Гострій Респіраторній Iнфекції recommended

Клінічна Допомога при Важкій Гострій Респіраторній Iнфекції
recommended